16 articles for A Boumendjel
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
2-Indolylmethylenebenzofuranones as first effective inhibitors of ABCC2.
Bmssi Umr 5086 Cnrs/Universit£
New, highly potent and non-toxic, chromone inhibitors of the human breast cancer resistance protein ABCG2.
University of Lyon 1
Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.
Bmssi Umr 5086 Cnrs/Universit£
Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein.
Cnrs/Universit£
Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2.
Umr 5063 Cnrs/Universit£
Refinement of arylthiosemicarbazone pharmacophore in inhibition of mushroom tyrosinase.
Universite Grenoble
Discovery of potent chromone-based autotaxin inhibitors inspired by cannabinoids.
European Molecular Biology Laboratory
Inhibitors of ABCG2-mediated multidrug resistance: Lead generation through computer-aided drug design.
University of Perugia
Exploiting HOPNO-dicopper center interaction to development of inhibitors for human tyrosinase.
University of Grenoble Alpes
Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes.
Umr-Cnrs 5063
Chromones bearing amino acid residues: Easily accessible and potent inhibitors of the breast cancer resistance protein ABCG2.
Cnrs
B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance.
DéPartement De Pharmacochimie MoléCulaire Umr-Cnrs 5063
Optimization of the chromone scaffold through QSAR and docking studies: Identification of potent inhibitors of ABCG2.
Univ. Grenoble Alpes
Structure-activity relationships of chromone derivatives toward the mechanism of interaction with and inhibition of breast cancer resistance protein ABCG2.
Bmssi Umr 5086 Cnrs/Universit£